Received Apr 10, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (NO BRAND NAME) | UNKNOWN MANUFACTURER | UNK | UNK | — |
headache; fatigue; This non-serious case was reported by a consumer via interactive digital media and described the occurrence of headache in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis. On an unknown date, the patient received Shingles vaccine. On an unknown date, an unknown time after receiving Shingles vaccine, the patient experienced headache (Verbatim: headache) and fatigue (Verbatim: fatigue). The outcome of the headache and fatigue were resolved (duration 3 days). It was unknown if the reporter considered the headache and fatigue to be related to Shingles vaccine. It was unknown if the company considered the headache and fatigue to be related to Shingles vaccine. Additional Information: GSK Receipt Date: 01-APR-2025 This case was reported by a patient via interactive digital media. The patient said vaccine knocked him/her for a loop twice: headache and fatigue for three days. But compared to the infection patient felt worth it.